HBI understands a quarter of the UK's pathology outsourcing contracts - and at least a half of its revenue - could switch hands over the next two years, which could potentially see a major shake-up of the market share among the top players.
Countries across the Asia-Pacific that are trying to implement UHC have seen more people paying for healthcare through compulsory and voluntary payment schemes.
Insurers and big occupational healthcare providers are sceptical about a new generation of lifestyle genetic testing linked to apps which are designed to enable individuals to achieve higher levels of wellness. But they are starting to deploy more specific tests that diagnose rare diseases. We talk to major operators and insurers about how they see the genetic test market.
A public consultation on competition in South Africa could lead to a relaxation on external investment in the laboratory market, Healthcare Europa hears.
Pan-Asian hospital operator IHH is likely to float SRL, the diagnostics arm of troubled hospital chain Fortis, next year, according to some local reports - but Healthcare Nova has heard different.
A public consultation on competition in South Africa could lead to a relaxation on external investment in the laboratory market, Healthcare Nova hears.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.